Systematic discovery of ectopic pregnancy serum biomarkers using 3-D protein profiling coupled with label-free quantitation

Journal of Proteome Research

Volumn 10, Issue 3, 2011, Pages 1126-1138

  Beer, Lynn A ^a   Tang, Hsin Yao ^a   Sriswasdi, Sira ^a,b   Barnhart, Kurt T ^b   Speicher, David W ^a,b  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

biomarker discovery; ectopic pregnancy; label free quantitation; multiple reaction monitoring; serum biomarkers; serum proteomes

Indexed keywords

ADAM12 PROTEIN; BIOLOGICAL MARKER; CHORIOGONADOTROPIN SUBUNIT BETA PRECURSOR; CHORIONIC SOMATOMAMMOTROPIN HORMONE PRECURSOR; GLYCOPROTEIN HORMONES ALPHA CHAIN PRECURSOR; ISOFORM 2 OF PREGNANCY SPECIFIC BETA 1 GLYCOPROTEIN 1; ISTHMIN 2; PAPPALYSIN 1 PRECURSOR; PREGNANCY SPECIFIC BETA 1 GLYCOPROTEIN 2 PRECURSOR; PREGNANCY SPECIFIC BETA 1 GLYCOPROTEIN 9; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN 11 ISOFORM 1; PROGESTAGEN ASSOCIATED ENDOMETRIAL PROTEIN; UNCLASSIFIED DRUG;

3 D PROTEIN PROFILING; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ECTOPIC PREGNANCY; FEMALE; HUMAN; LABEL FREE QUANTITATION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PREGNANCY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION;

ADAM PROTEINS; AMINO ACID SEQUENCE; BIOLOGICAL MARKERS; BLOOD PROTEINS; CHROMATOGRAPHY, LIQUID; DATABASES, PROTEIN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; PREGNANCY; PREGNANCY, ECTOPIC; PROTEOME; PROTEOMICS; TANDEM MASS SPECTROMETRY;

EID: 79952437118     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr1008866     Document Type: Article

References (38)

1. Anderson, N. L.; Anderson, N. G. The human plasma proteome: history, character, and diagnostic prospects Mol. Cell. Proteomics 2002, 1 (11) 845-67
2. Anderson, N. L. The roles of multiple proteomic platforms in a pipeline for new diagnostics Mol. Cell. Proteomics 2005, 4 (10) 1441-4 (Pubitemid 41555470)
3. Rifai, N.; Gillette, M. A.; Carr, S. A. Protein biomarker discovery and validation: the long and uncertain path to clinical utility Nat. Biotechnol. 2006, 24 (8) 971-83 (Pubitemid 44215392)
4. Anderson, N. L. The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum Clin. Chem. 2010, 56 (2) 177-85
5. Gerton, G. L.; Fan, X. J.; Chittams, J.; Sammel, M.; Hummel, A.; Strauss, J. F.; Barnhart, K. A serum proteomics approach to the diagnosis of ectopic pregnancy Ann. N.Y. Acad. Sci. 2004, 1022, 306-16 (Pubitemid 38951618)
6. Choolani, M.; Narasimhan, K.; Kolla, V.; Hahn, S. Proteomic technologies for prenatal diagnostics: advances and challenges ahead Expert Rev. Proteomics 2009, 6 (1) 87-101
7. Cabar, F. R.; Fettback, P. B.; Pereira, P. P.; Zugaib, M. Serum markers in the diagnosis of tubal pregnancy Clinics (Sao Paulo) 2008, 63 (5) 701-8
8. Cartwright, J.; Duncan, W. C.; Critchley, H. O.; Horne, A. W. Serum biomarkers of tubal ectopic pregnancy: current candidates and future possibilities Reproduction 2009, 138 (1) 9-22
9. Barnhart, K. T. Clinical practice. Ectopic pregnancy N. Engl. J. Med. 2009, 361 (4) 379-87
10. Seeber, B. E.; Barnhart, K. T. Suspected ectopic pregnancy Obstet. Gynecol. 2006, 107 (2 Pt 1) 399-413
11. Hoover, K. W.; Tao, G.; Kent, C. K. Trends in the diagnosis and treatment of ectopic pregnancy in the United States Obstet. Gynecol. 2010, 115 (3) 495-502
12. Daponte, A.; Pournaras, S.; Zintzaras, E.; Kallitsaris, A.; Lialios, G.; Maniatis, A. N.; Messinis, I. E. The value of a single combined measurement of VEGF, glycodelin, progesterone, PAPP-A, HPL and LIF for differentiating between ectopic and abnormal intrauterine pregnancy Hum. Reprod. 2005, 20 (11) 3163-6 (Pubitemid 41662672)
13. Mueller, M. D.; Raio, L.; Spoerri, S.; Ghezzi, F.; Dreher, E.; Bersinger, N. A. Novel placental and nonplacental serum markers in ectopic versus normal intrauterine pregnancy Fertil. Steril. 2004, 81 (4) 1106-11 (Pubitemid 38452981)
14. Abbott, J.; Emmans, L. S.; Lowenstein, S. R. Ectopic pregnancy: ten common pitfalls in diagnosis Am. J. Emerg. Med. 1990, 8 (6) 515-22
15. Tay, J. I.; Moore, J.; Walker, J. J. Ectopic pregnancy Br. Med. J. 2000, 320 (7239) 916-9 (Pubitemid 30182389)
16. Omenn, G. S.; States, D. J.; Adamski, M.; Blackwell, T. W.; Menon, R.; Hermjakob, H.; Apweiler, R.; Haab, B. B.; Simpson, R. J.; Eddes, J. S.; Kapp, E. A.; Moritz, R. L.; Chan, D. W.; Rai, A. J.; Admon, A.; Aebersold, R.; Eng, J.; Hancock, W. S.; Hefta, S. A.; Meyer, H.; Paik, Y. K.; Yoo, J. S.; Ping, P.; Pounds, J.; Adkins, J.; Qian, X.; Wang, R.; Wasinger, V.; Wu, C. Y.; Zhao, X.; Zeng, R.; Archakov, A.; Tsugita, A.; Beer, I.; Pandey, A.; Pisano, M.; Andrews, P.; Tammen, H.; Speicher, D. W.; Hanash, S. M. Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database Proteomics 2005, 5 (13) 3226-45 (Pubitemid 41192032)
17. States, D. J.; Omenn, G. S.; Blackwell, T. W.; Fermin, D.; Eng, J.; Speicher, D. W.; Hanash, S. M. Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study Nat. Biotechnol. 2006, 24 (3) 333-8 (Pubitemid 43372157)
18. Echan, L. A.; Tang, H. Y.; Ali-Khan, N.; Lee, K.; Speicher, D. W. Depletion of multiple high-abundance proteins improves protein profiling capacities of human serum and plasma Proteomics 2005, 5 (13) 3292-303 (Pubitemid 41192036)
19. Bjorhall, K.; Miliotis, T.; Davidsson, P. Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples Proteomics 2005, 5 (1) 307-17 (Pubitemid 40189661)
20. Beer, L. A.; Speicher, D. W. Immunoaffinity depletion of high abundance plasma and serum proteims. In The Protein Protocols Handbook, 3 rd ed.; Humana Press: New York, 2009.
21. Fang, Y.; Robinson, D. P.; Foster, L. J. Quantitative analysis of proteome coverage and recovery rates for upstream fractionation methods in proteomics J. Proteome Res. 2010, 9 (4) 1902-12
22. Piersma, S. R.; Fiedler, U.; Span, S.; Lingnau, A.; Pham, T. V.; Hoffmann, S.; Kubbutat, M. H.; Jimenez, C. R. Workflow comparison for label-free, quantitative secretome proteomics for cancer biomarker discovery: method evaluation, differential analysis, and verification in serum J. Proteome Res. 2010, 9 (4) 1913-22
23. Tang, H. Y.; Ali-Khan, N.; Echan, L. A.; Levenkova, N.; Rux, J. J.; Speicher, D. W. A novel four-dimensional strategy combining protein and peptide separation methods enables detection of low-abundance proteins in human plasma and serum proteomes Proteomics 2005, 5 (13) 3329-42 (Pubitemid 41192039)
24. Old, W. M.; Meyer-Arendt, K.; Aveline-Wolf, L.; Pierce, K. G.; Mendoza, A.; Sevinsky, J. R.; Resing, K. A.; Ahn, N. G. Comparison of label-free methods for quantifying human proteins by shotgun proteomics Mol. Cell. Proteomics 2005, 4 (10) 1487-502 (Pubitemid 41555475)
25. Zhu, W.; Smith, J. W.; Huang, C. M. Mass spectrometry-based label-free quantitative proteomics J. Biomed. Biotechnol. 2010, 2010, 840518
26. Elliott, M. H.; Smith, D. S.; Parker, C. E.; Borchers, C. Current trends in quantitative proteomics J. Mass Spectrom. 2009, 44 (12) 1637-60
27. Mueller, L. N.; Brusniak, M. Y.; Mani, D. R.; Aebersold, R. An assessment of software solutions for the analysis of mass spectrometry based quantitative proteomics data J. Proteome Res. 2008, 7 (1) 51-61 (Pubitemid 351171115)
28. This software is no longer commercially developed as a result of the purchase of Rosetta Biosoftware by Microsoft Corporation.
29. Paweletz, C. P.; Wiener, M. C.; Bondarenko, A. Y.; Yates, N. A.; Song, Q.; Liaw, A.; Lee, A. Y.; Hunt, B. T.; Henle, E. S.; Meng, F.; Sleph, H. F.; Holahan, M.; Sankaranarayanan, S.; Simon, A. J.; Settlage, R. E.; Sachs, J. R.; Shearman, M.; Sachs, A. B.; Cook, J. J.; Hendrickson, R. C. Application of an end-to-end biomarker discovery platform to identify target engagement markers in cerebrospinal fluid by high resolution differential mass spectrometry J. Proteome Res. 2010, 9 (3) 1392-401
30. Neubert, H.; Bonnert, T. P.; Rumpel, K.; Hunt, B. T.; Henle, E. S.; James, I. T. Label-free detection of differential protein expression by LC/MALDI mass spectrometry J. Proteome Res. 2008, 7 (6) 2270-9
31. Rosetta Elucidator System v. 3.1 User Guide.
32. Nesvizhskii, A. I.; Keller, A.; Kolker, E.; Aebersold, R. A statistical model for identifying proteins by tandem mass spectrometry Anal. Chem. 2003, 75 (17) 4646-58 (Pubitemid 37082259)
33. Keller, A.; Nesvizhskii, A. I.; Kolker, E.; Aebersold, R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search Anal. Chem. 2002, 74 (20) 5383-92 (Pubitemid 35215372)
34. Wang, H.; Chang-Wong, T.; Tang, H. Y.; Speicher, D. W. Comparison of extensive protein fractionation and repetitive LC-MS/MS analyses on depth of analysis for complex proteomes J. Proteome Res. 2010, 9 (2) 1032-40
35. Anderson, L. Candidate-based proteomics in the search for biomarkers of cardiovascular disease J. Physiol. 2005, 563 (Pt 1) 23-60
36. Larsen, M. B.; Stephens, R. W.; Brunner, N.; Nielsen, H. J.; Engelholm, L. H.; Christensen, I. J.; Stetler-Stevenson, W. G.; Hoyer-Hansen, G. Quantification of tissue inhibitor of metalloproteinases 2 in plasma from healthy donors and cancer patients Scand. J. Immunol. 2005, 61 (5) 449-60 (Pubitemid 40695016)
37. Steen, H.; Mann, M. The ABCs (and XYZs) of peptide sequencing Nat. Rev. Mol. Cell. Biol. 2004, 5 (9) 699-711
38. Wewer, U. M.; Morgelin, M.; Holck, P.; Jacobsen, J.; Lydolph, M. C.; Johnsen, A. H.; Kveiborg, M.; Albrechtsen, R. ADAM12 is a four-leafed clover: the excised prodomain remains bound to the mature enzyme J. Biol. Chem. 2006, 281 (14) 9418-22 (Pubitemid 43864658)